Distinct T cell receptor signaling requirements for perform- or FasL-mediated cytotoxicity

Journal of Experimental Medicine

Volumn 183, Issue 4, 1996, Pages 1697-1706

  Esser, Mark T ^a   Krishnamurthy, Barath ^a   Lam Braciale, Vivian ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD8 ANTIGEN; CYCLOSPORIN A; FAS ANTIGEN; GAMMA INTERFERON; IONOMYCIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PERFORIN; PHORBOL 13 ACETATE 12 MYRISTATE; RECOMBINANT INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR; THAPSIGARGIN;

ANIMAL CELL; ARTICLE; CALCIUM MOBILIZATION; CELLULAR IMMUNITY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; INFLUENZA VIRUS; LYMPHOCYTE CLONE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; CALCIUM; CD8-POSITIVE T-LYMPHOCYTES; CYTOPLASMIC GRANULES; CYTOTOXICITY, IMMUNOLOGIC; EXOCYTOSIS; FAS LIGAND PROTEIN; INTERFERON TYPE II; IONOMYCIN; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE; PORE FORMING CYTOTOXIC PROTEINS; RECEPTORS, ANTIGEN, T-CELL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, CYTOTOXIC; TETRADECANOYLPHORBOL ACETATE;

EID: 0029914913     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.4.1697     Document Type: Article

References (66)

1. + independent T cell-mediated cytotoxicity. J. Exp. Med. 177:195-200.
2. Walsh, C., A. Glass, V. Chiu, and W. Clark. 1994. The role of the Fas lytic pathway in a perforin-less CTL hybridoma. J. Immunol. 153:2506-2514.
3. Henkart, P 1994. Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity. 1:343-346.
4. + cytotoxic T cells. Proc. Natl. Acad. Sci. USA. 91:4185-4189.
5. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K Olsen, E. Podack, R. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature (Lond.). 369:31-37.
6. Kagi, D., F. Vignaux, B. Ledermann, K. Burki, V. Depraetere, S. Nagata, H. Hengartner, and P. Golstein. 1994. Fas and perform pathways as major mechanisms of T cell-mediatcd cytotoxicity. Science (Wash. DC). 265:528-530.
7. Kojima, H., N. Shinohara, S. Hanaoka, Y. Someya-Shirota, Y. Takagaki, H. Ohno, T.S. Katayama, H. Yagita, K. Okumura, T. Saito et al. 1994. Two distinct pathways of specific killing revealed by perform mutant cytototoxic T lymphocytes. Immunity. 1:357-364.
8. Lowin, B., M. Hahne, C. Mattmann, and J. Tschopp. 1994. Cytolytic T-cell cytotoxicity is mediated through perform and Fas lytic pathways. Nature (Lond.). 370:650-652.
9. Hanabuchi, S., M. Koyanagi, A. Kawasaki, N. Shinohara, A. Matsuzawa, Y. Nishimura, Y. Kobayashi, S. Yonehara, H. Yagita, and K Okumura. 1994. Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity. Proc. Natl. Acad. Sci. USA. 91:4930-4934.
10. Anel, A., M. Buferne, C. Boyer, V.A. Schmitt, and P. Golstein. 1994. T cell receptor-induced Fas ligand expression in cytotoxic T lymphocyte clones is blocked by protein tyrosine kinase inhibitors and cyclosporin A. Eur. J. Immunol. 24: 2469-2476.
11. Liu, C., C. Walsh, and J. Young. 1995. Perforin: structure and function, Immunol. Today. 16:194-201.
12. Smyth, M., and J. Trapani. 1995. Granzymes: exogenous proteinases that induce target cell apoptosis. Immunol. Today. 16:202-206
13. Peters, P., H. Geuze, H. Van der Donk, J. Slot, J. Griffith, N. Stam, H. Clevers, and J. Borst. 1989. Molecules relevant for T cell-target cell interaction are present in cytolytic granules of human T lymphocytes. Eur.J. Immunol. 19:1469-1475.
14. Zagury, D., J. Bernard, N. Thierness, M. Feldman, and G. Berke. 1975. Isolation and characterization of individual functionally reactive cytotoxic T lymphocytes: conjugation, killing and recycling at the single cell level. Eur. J. Immunol. 5: 818-822.
15. Vignaux, F., E. Vivier, B. Malissen, V. Depraetere, S. Nagata, and P. Golstein. 1995. TCR/CD3 coupling to Fas-based cytotoxicity. J. Exp. Med. 181:781-786.
16. Vignaux, F., and P. Golstein. 1994. Fas-based lymphocytemediated cytotoxicity against syngeneic activated lymphocytes: a regulatory pathway? Eur. J. Immunol. 24:923-927.
17. Singer, G., and A. Abbas. 1994. The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity. 1:365-371.
18. Alderson, M., T. Tough, T. Davis-Smith, S. Braddy, B. Falk, K. Schooley, R. Goodwin, C. Smith, F. Ramsdell, and D. Lynch. 1995. Fas ligand mediates acitvation-induced cell death in human T lymphocytes. J. Exp. Med 181:71-77.
19. Brunner, T., R. Mogil, D. LaFace, N. Yoo, A. Mahboubi, F. Echevem, S. Martin, W. Force, D. Lynch, and C. Ware et al. 1995. Cell-autonomous Fas(CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature (Lond.) 373:441-444.
20. Dhein, J., H. Walczak. H. Baumler, K. Debatin, and P. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1 (Fas/CD95). Nature (Lond.). 373:438-441.
21. Ju, S.T., D. Panka, H. Cui, R. Ettinger, M. el-Khatib, D. Sherr, B. Stanger, and A. Marshak-Rothstein. 1995. Fas(CD95) FasL interactions required for programmed cell-death after T-cell activation. Nature (Lond.). 373:444-448.
22. Cheng, J., T. Zhou, C. Liu, J. Shapiro, M. Brauer, M. Kiefer, P. Barr, and J. Mountz. 1994. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science (Wash. DC). 263:1759-1762.
23. Braciale, T., M. Sweetser, L. Morrison, D. Kittlesen, and V. Braciale. 1989. Class I major histocompatibility complexrestricted cytolytic T lymphocytes recognize a limited number of sites on the influenza hemagglutinin. Proc. Natl. Acad. Sci. USA. 86:277-281.
24. Andrew, M., V. Braciale, and T. Braciale. 1984. Regulation of interleukin 2 receptor expression on murine cytotoxic T lymphocyte clones. J. Immunol. 132:839-844.
25. Braciale, T.J., M.E. Andrew, and V.L. Braciale. 1981. Heterogeneity and specificity of cloned lines of influenza virusspecific cytotoxic T lymphocytes. J. Exp. Med 153:910-923.
26. Haverstick, D.M., V.H. Engelhard, and L.S. Gray. 1991. Three intracellular signals for cytotoxic T lymphocyte-mediated killing. J. Immunol. 146:3306-3313.
27. Leo, O., M. Foo, D. Sachs, L. Samelson. and J Bluestone. 1987. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc. Natl. Acad. Sci. USA. 84:1374-1378.
28. Kubo, R., W. Born, J. Kappler, P. Marrack, and M. Pigeon. 1989. Characterization of a monoclonal antibody which detects all murine alpha beta T cell receptors. J. Immunol. 142: 2736-2742.
29. Sarmiento, M., D. Dialynas, D. Lancki, K. Wall, M. Lorber, M. Loken, and F. Fitch. 1982. Cloned T lymphocytes and monoclonal antibodies as probes for cell surface molecules active in T cell-mediated cytolysis. Immunol. Rev. 68:135-169.
30. Malek, T., R. Robb, and E. Shevach. 1983. Identification and initial characterization of a rat monoclonal antibody reactive with the mnrine interleukin 2 receptor-ligand complex. Proc. Natl. Acad. Sci. USA. 80:5694-5698.
31. Ledbetter, J., and L. Herzenberg. 1979. Xenogenic monoclonal antibodies to mouse lymphoid differentiation antigens. Immunol. Rev. 47:63-90.
32. Schreiber, R. 1991. Measurement of mouse and human interferon-gamma. In Current Protocols in Immunology. J. Coligan, A. Kruisbeek, D. Marqulies, and W. Strober, editors. John Wiley & Sons Inc., New York. 6.8.1-6.8.8.
33. Takayama, H., G. Trenn, W. Humphrey, J. Bluestone, P. Henkart, and M. Sitkovsky. 1987. Antigen receptor triggered secretion of a trypsin-type esterase from cytotoxic T lymphocytes. J Immunol. 138:566-569.
34. Henkel, T.J., V.L. Braciale, and T.J. Braciale. 1987. Anti-T cell receptor antibodies fail to inhibit specific lysis by CTL clones but activate lytic activity for irrelevant targets. J. Immunol. 138:1221-1228.
35. Gray, L., J. Gnarra, and V. Engelhard. 1987. Demonstration of a calcium influx cytolytic T lymphocytes in response to target cell binding. J. Immunol. 138:63-69.
36. Imboden, J., and J. Stobo. 1985. Transmembrane signalling by the T cell antigen receptor. Perturbation of the T3-antigen receptor complex generates inositol phosphates and releases calcium ions from intracellular stores. J. Exp. Med. 161:446-456.
37. Nisbet-Brown, E., R. Cheung, J. Lee, and E. Gelfand. 1985. Antigen-dependent increase in cytosolic free calcium in specific human T-lymphocyte clones. Nature (Lond.). 316:545-547.
38. 2+ in activation of mature cytotoxic T lymphocytes for lysis. J. Immunol. 139:3537-3579.
39. 2+ ATPasc. Proc. Natl. Acad. Sci. USA. 87:2466-2470.
40. Mueller, D., and M. Jenkins. 1995. Molecular mechanisms of underlying functional T-cell unresponsiveness. Curr. Opin. Immunol. 7:375-381.
41. Podack, E. 1995. Execution and suicide: cytotoxic lymphocytes enforce Draconian laws through separate molecular pathways. Curr. Opin. Immunol. 7:11-16.
42. Crispe, I. 1994. Fatal interactions: Fas-induced apoptosis of mature T cells. Immunity. 1:347-349.
43. Cohen, P., and R. Eisenberg. 1991. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9:243-269.
44. Singer, G., A. Carrera, A. Marshak-Rothstein, C. Martinez, and A. Abbas. 1994. Apoptosis, Fas and systemic autoimmunity: the MRL-lpr/lpr model. Curr. Opin. Immunol. 6:913-920.
45. Nagata, S., and T. Suda. 1995. Fas and Fas ligand: lpr and gld mutations. Immunol. Today. 16:39-43.
46. Ogasawara, J., R. Watanabe-Fukunaga, M. Adachi, A. Matsuzawa, T. Kasugai, Y. Kitamura, N. Itoh, T. Suda, and S. Nagata. 1993. Lethal effect of the anti-Fas antibody in mice. Nature (Lond.). 364:806-809.
47. + T cells responding to a bacterial superantigen. J. Immunol. 154:4302-4308.
48. Westendorp, M., R. Frank, C. Ochenbauer, K. Stricker, J. Dhein, H. Walczak, K. Debatin, and P. Krammer. 1995. Scnsitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature (Lond.). 375:497-500.
49. + T cells by a selfderived peptide. Nature (Lond.). 378:295-298.
50. Irving, B., and A. Weiss. 1991. The cytoplasmic domain of the T cell receptor zeta chain is sufficient to couple to receptor-associated signal transduction pathways. Cell. 64:891-901.
51. Weissman, A. 1994. The T-cell antigen receptor: a multisubunit signaling complex. In Lymphocyte Activation. L.E. Samuelson, editor. Karger, Basel, Switzerland. 59:1-18.
52. Peri, K., and A. Veillette. 1994. Tyrosine protein kinases in T lymphocytes. In Lymphocyte Activation. L.E. Samuelson, editor. Karger, Basel, Switzerland. 59:19-39.
53. Sloan-Lancaster, J., A. Shaw, J. Rothbard, and P. Allen. 1994. Partial T cell signaling: altered phospho-zeta and lack of Zap70 recruitment in APL-induced T cell anergy. Cell. 79:913-922.
54. Sloan-Lancaster, J., and P. Allen. 1995. Significance of T-cell stimulation by altered peptide ligands in T cell biology. Curr. Opin. Immunol. 7:103-109.
55. Heldin, C. 1995. Dimerization of cell surface receptors in signal transduction. Cell. 80:213-223.
56. Cantrell, D., M. Izquierdo-Pastor, K. Reif, and M. Woodrow. 1994. Signal transduction by the T-cell antigen receptor: regulation and function of p21ras and PtdIns-3 kinase. In Lymphocyte Activation. L.E. Samuelson, editor. Karger, Basel, Switzerland. 59:115-127.
57. Izquierdo-Pastor, M., S. Leevers, C. Marshal, and D. Cantrell. 1993. p21ras couples the T cell antigen receptor to extracellular signal-regulated kinase in T lymphocytes. J. Exp. Med. 178:1199-1208.
58. Izquierdo-Pastor, M., K. Reif, and D. Cantrell. 1995. The regulation and function of p21ras during T-cell activation and growth. Immunol. Today. 16:159-164.
59. Bierer, B. 1994. Cyclosporin A, FK506, and rapamycin: binding to immunophilins and biological action. In Lympho-cyte Activation. L.E. Samuelson, editor. Karger, Basel, Switzerland. 59:128-155.
60. Gajewski, T., D. Lancki, R. Stack, and F. Fitch. 1994. "Anergy'of TH0 helper T lymphocytes induces downregulation of TH1 characteristics and a transition to a TH2-like phenotype. J. Exp. Med. 179:481-491.
61. Gajewski, T., D. Qian, P. Fields, and F. Fitch. 1994. Anergic T-lymphocyte clones have altered inositol phosphate, calcium, and tyrosine kinase signaling pathways. Proc. Natl. Acad. Sci. USA. 91:38-42.
62. Trenn, G., R. Taffs, R. Hohman, R. Kincaid, E. Shevach, and M. Sitkovsky. 1989. Biochemical characterization of the inhibitory effector of CsA on cytolytic T lymphocyte effector functions. J. Immunol. 142:3796-3802.
63. Lancki, D., B. Kaper, and F. Fitch. 1989. The requirements for triggering of lysis by cytolytic T lymphocyte clones. II. Cyclosporin A inhibits TCR-mediated exocytosis but only selectively inhibits TCR-mediated lytic activity by cloned CTL. J. Immunol. 142:416-424.
64. Strack, P., C. Martin, S. Saito, R. Dekruyff, and S. Ju. 1990. Metabolic inhibitors distinguish cytolytic activity of CD4 and CD8 clones. Eur. J. Immunol. 20:179-184.
65. Smyth, M., Y. Norihisa, and J. Ortaldo. 1992. Multiple cytolytic mechanisms displayed by activated human peripheral blood T cell subsets. J. Immunol. 148:55-62.
66. Isaaz, S., K. Baetz, K. Olsen, E. Podack, and G. Griffiths. 1995. Serial killing by cytotoxic T lymphocytes: T cell receptor triggers degranulation, re-filling of the lytic granules and secretion of lytic proteins via a nongranule pathway. Eur. J. Immunol. 25:1071-1079.